Operational Research for Cryptococcal Antigen Screening

PHASE4CompletedINTERVENTIONAL
Enrollment

3,049

Participants

Timeline

Start Date

July 1, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Cryptococcal MeningitisCryptococcus NeoformansCryptococcosis
Interventions
DRUG

Fluconazole

Fluconazole 800mg orally daily for 2 weeks, then 400mg daily for 8 weeks

Trial Locations (2)

Unknown

Infectious Disease Institute, Makerere University, Kampala

Kampala Capital Council Authority Clinics, Kampala

All Listed Sponsors
collaborator

Infectious Diseases Institute, Uganda

OTHER

collaborator

Makerere University

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

University of Minnesota

OTHER

NCT01535469 - Operational Research for Cryptococcal Antigen Screening | Biotech Hunter | Biotech Hunter